galantamine and Nausea

galantamine has been researched along with Nausea in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miyazaki, S1
Kertesz, A1
Brashear, HR; Dunbar, F; Zhu, Y1
Gallini, A; Montastruc, JL; Salandini, AM; Sommet, A; Veyssière, P1

Trials

2 trial(s) available for galantamine and Nausea

ArticleYear
Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial.
    Current neurology and neuroscience reports, 2002, Volume: 2, Issue:6

    Topics: Alzheimer Disease; Cerebrovascular Disorders; Cholinesterase Inhibitors; Dementia, Vascular; Double-Blind Method; Galantamine; Humans; Nausea; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome; Vomiting

2002
Post hoc comparison of daily rates of nausea and vomiting with once- and twice-daily galantamine from a double-blind, placebo-controlled, parallel-group, 6-month study.
    Clinical therapeutics, 2006, Volume: 28, Issue:3

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antiemetics; Cholinesterase Inhibitors; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Galantamine; Humans; Male; Middle Aged; Nausea; Vomiting

2006

Other Studies

3 other study(ies) available for galantamine and Nausea

ArticleYear
[Narcissus].
    Chudoku kenkyu : Chudoku Kenkyukai jun kikanshi = The Japanese journal of toxicology, 2014, Volume: 27, Issue:1

    Topics: Abdominal Pain; Amaryllidaceae Alkaloids; Animals; Foodborne Diseases; Galantamine; Humans; Narcissus; Nausea; Phenanthridines

2014
Weight-loss associated with anti-dementia drugs in a patient with Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2007, Oct-15, Volume: 22, Issue:13

    Topics: Adverse Drug Reaction Reporting Systems; Aged; Anorexia; Antiparkinson Agents; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Galantamine; Humans; Lewy Body Disease; Memantine; Mental Status Schedule; Nausea; Nootropic Agents; Parkinson Disease; Vomiting; Weight Loss

2007
Galantamine (reminyl) for Alzheimer's disease.
    The Medical letter on drugs and therapeutics, 2001, Jun-25, Volume: 43, Issue:1107

    Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Diarrhea; Dizziness; Dose-Response Relationship, Drug; Galantamine; Humans; Nausea; Vomiting

2001